Kang Xiaoqiang, chairman of Weili Zhibo-B (09887), plans to increase the company's H shares by no more than HK$20 million

Zhitongcaijing · 1d ago

Zhitong Finance App News, Weilizhibo-B (09887) issued an announcement. The board of directors of the company was notified by Dr. Kang Xiaoqiang (Dr. Kang), Chairman, Executive Director, CEO and General Manager of the Company. Based on recognition of the company's value and confidence in the company's overall future business development and growth potential, Dr. Kang plans to increase its H shares (H shares) in the open market within about 6 months from the date of this announcement. The total cost of the increase is expected to not exceed HK$20 million (increase in holdings plan), subject to compliance with the Hong Kong Stock Exchange Limited company securities listing rules and other applicable laws and regulations. Dr. Kang may increase his H shares holdings of the Company from time to time in accordance with market conditions and applicable regulatory requirements.

As of the date of this announcement, Dr. Kang owns or is deemed to have an interest in a total of 295.03 million H shares, accounting for about 14.92% of the issued H shares and about 14.83% of the total issued share capital of the Company.

According to the information available to the Company and the knowledge and beliefs of the directors, if the plan to increase holdings is fully implemented, the Company will still maintain sufficient public shareholding in the issued H shares.

The Board believes that the plan to increase holdings reflects Dr. Kang's firm confidence in the company's value and long-term development prospects.